Accordingly, the APOL3‐controlled NCS‐1 is known to promote motility, metastatic spread and survival of cancer cells [106, 107], and the NCS‐1 antagonist CALN‐1 also exhibits relationship with metastatic cell migration [108]. This evidence concerns the gene NCS1 and cancer.